Awakn Life Sciences Corp. (AWKNF)

USD 0.07

(0.0%)

Market Cap (In USD)

2.7 Million

Revenue (In USD)

87.37 Thousand

Net Income (In USD)

-5.1 Million

Avg. Volume

7931.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.04872-0.1877
PE
-
EPS
-
Beta Value
2.66
ISIN
CA05455W1086
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Anthony Tennyson
Employee Count
-
Website
https://awaknlifesciences.com
Ipo Date
2021-08-03
Details
Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Toronto, Canada.